Press release / 21.11.22


Dear shareholders,

Our general meeting was convened through the SOGC (Swiss Official Gazette of Commerce) within the deadlines provided by law.

However, we communicate this invitation because we know that some shareholders are not in the habit of consulting this type of official publication.

Therefore, you will find this invitation to the General Assembly to be held on Monday, November 28, 2022 at 2 pm at the Café-restaurante des Tonneliers in Bulle (Switzerland). The agenda, preferred registration form, delegation power and invitation to participate are attached to this letter.

As part of this meeting, we are going to carry out a capital increase. As existing shareholders, you have a preferential subscription right that we suggest you exercise within the next 5 days, returning the subscription form and paying the subscription amount within the same period. All preferred subscription details appear on our subscription form sent to you.

In addition, we kindly ask you to inform us of your presence via the registration form by Friday, November 25, 2022, at 5:00 pm. In case of absence on your part, you have the possibility to be represented by a person of your choice. That person must be physically present at this meeting with your attorney.

To prove your status as a shareholder, it is essential that you submit a statement of your position in Bebo Health SA securities held at your bank.

Our company is currently in full expansion and we must ensure this development through a substantial capital contribution. An investor has expressed a desire to join us, which is why a capital increase is essential. This investor has already paid €3,625,000 in exchange for 725,000 shares, ie at a price of €5.–. Your preemptive subscription right therefore allows you to invest in our company at a price of €5.– per share.

At the same time, allow me, as President, to inform you about the various highlights of our company’s life during 2021 and 2022, as well as the perspectives for 2023.

The year 2021 was marked by preparatory work for our IPO, as well as the development of our company.

On 01.12.2022, we went public on the Euronext Access sector of the Paris Stock Exchange.


– End of the COVID period with an average drop in e-commerce sales of 35%.

– February 24: Start of the war in Ukraine and, in our view, a same-day hack, resulting in a 90% reduction in website visits.

– Despite this, our cumulative growth in the third quarter of 2022 is 27% compared to 2021 (4,028 KCHF) for an EBITDA of 648 KCHF, also up sharply.

– Our forecasts for the end of 2022 are for a total turnover of KCHF 6,200 (KCHF 4,455 in 2021) for an EBITDA of 20% (18.5% in 2021).

– For 2022 and 2023, we will continue our development by establishing BEBO HUB centers and opening new countries through e-commerce. This strategy involves the allocation of funds initiated in the last quarter.


– The introductory price (€18.50) has been heavily readjusted (€8.25 on 21/11/22).

– We all know that the ACCESS segment is not representative of the market value of a company, it is 100 times less “liquid” than the top segment (CRESCER).

– We decided to move on to the latter to give shareholders the possibility to trade their shares.

– This migration scheduled for spring 2022 will be accompanied by very strong communication both for our performance and for our objectives.

– The Board of Directors and I are very sensitive to stock market valuation and shareholder earnings.

– For this year, unfortunately, we noticed that the ACCESS segment of EURONEXT is not dynamic and we suffer from the vagaries of world markets (COVID, war, inflation, risk of shortages).

– The market trend is increasingly in search of profits and sales performance. In this context, BEBO is perfectly suited.

I remain at your disposal.





Founded in 2019, BEBO Health SA (Euronext Access – MLBBO) specializes in the online distribution of health, sports and wellness products for individuals (BtoC) and professionals (BtoB). The company offers slimming belts that allow a massive elimination of excess fat (SLIM SONIC), a body shaper for the treatment of cellulite (CELLISS), products for controlling body temperature and personal air conditioners (SNØ ), as well as supplements food (MAIDAY). The company develops its activities through the 4 exclusive brands it represents and the 4 corresponding websites available worldwide. In 2021, BEBO Health SA achieved a turnover of CHF 5.5 million, an increase of +170%.


“This document does not constitute an offer to sell or solicitation of an offer to buy securities of BEBO Health SA. If you would like more complete information about BEBO Health SA, we invite you to consult the public documents available on our website ( This document may contain certain forward-looking statements. Although the Company believes that these statements are based on reasonable assumptions as of the date of publication of this press release, they are, by their nature, subject to risks and uncertainties that could lead to a difference between the actual numbers and those indicated or implied in these statements . 🇧🇷



Jean-Charles Juriens

General secretary

Email :

Telephone : +41 79 353 38 44

Leave a Comment